Risk factors for thrombosis in cancer patients

Aneel A. Ashrani, John A. Heit

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Scopus citations

Abstract

Venous thromboembolism (VTE), comprised of deep vein thrombosis (DVT) and its complication, pulmonary embolism (PE), is a multifactorial disease, involving complex interactions between environmental exposures and patients, including their hemostatic system and genetic predispositions. VTE is relatively common, with an overall average age- and sex-adjusted incidence of about 1.04-1.9 per 1000 person-years that rises dramatically with increasing age [1-4]. Active malignancy accounts for almost 20% of incident VTE events occurring in the community [5], and imparts a 4- to 6.5-fold higher VTE risk compared to non-cancer patients, depending on concurrent use of anti-cancer therapy [6]. The risk of VTE also varies by cancer type and stage [7-10]. The association between VTE and malignancy has been recognized since 1861 when Trousseau, in a lecture, described thrombophlebitis as the presenting sign of visceral malignancy [11].

Original languageEnglish (US)
Title of host publicationCoagulation in Cancer
Pages95-114
Number of pages20
DOIs
StatePublished - May 6 2009

Publication series

NameCancer Treatment and Research
Volume148
ISSN (Print)0927-3042

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Ashrani, A. A., & Heit, J. A. (2009). Risk factors for thrombosis in cancer patients. In Coagulation in Cancer (pp. 95-114). (Cancer Treatment and Research; Vol. 148). https://doi.org/10.1007/978-0-387-79962-9_7